Amgen Inc.
AMGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $9,557 | $9,167 | $8,149 | $9,086 |
| % Growth | 4.3% | 12.5% | -10.3% | – |
| Cost of Goods Sold | $3,082 | $3,011 | $2,968 | $3,112 |
| Gross Profit | $6,475 | $6,156 | $5,181 | $5,974 |
| % Margin | 67.8% | 67.2% | 63.6% | 65.7% |
| R&D Expenses | $1,900 | $1,744 | $1,486 | $1,724 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1,720 | $1,691 | $1,687 | $1,878 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $329 | $77 | $830 | $61 |
| Operating Expenses | $3,949 | $3,512 | $4,003 | $3,663 |
| Operating Income | $2,526 | $2,644 | $1,178 | $2,311 |
| % Margin | 26.4% | 28.8% | 14.5% | 25.4% |
| Other Income/Exp. Net | $1,395 | -$1,076 | $795 | -$1,529 |
| Pre-Tax Income | $3,921 | $1,568 | $1,973 | $782 |
| Tax Expense | $705 | $136 | $243 | $155 |
| Net Income | $3,216 | $1,432 | $1,730 | $627 |
| % Margin | 33.7% | 15.6% | 21.2% | 6.9% |
| EPS | 5.98 | 2.66 | 3.22 | 1.17 |
| % Growth | 124.8% | -17.4% | 175.2% | – |
| EPS Diluted | 5.93 | 2.65 | 3.2 | 1.16 |
| Weighted Avg Shares Out | 538 | 538 | 538 | 541 |
| Weighted Avg Shares Out Dil | 542 | 541 | 541 | 542 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $685 | $708 | $723 | $747 |
| Depreciation & Amortization | $1,307 | $1,341 | $1,387 | $1,397 |
| EBITDA | $5,913 | $3,617 | $4,083 | $2,926 |
| % Margin | 61.9% | 39.5% | 50.1% | 32.2% |